ABSTRACT INTELECTIN (ITLN) is an adipokine involved in the regulation of insulin sensitivity and inflammatory and immunity responses. Serum ITLN levels are lower in obese, diabetic, and polycystic ovary syndrome (PCOS) women than in control subjects. ITLN has never been studied in ovarian cells. Here, we identified ITLN1 in human ovarian follicles and investigated the molecular mechanisms involved in the regulation of its expression in response to the insulin sensitizers metformin and rosiglitazone, in human granulosa-lutein cells (hGLCs) and in a human ovarian granulosa-like tumor cell line (KGN). We also studied the effects of human recombinant ITLN1 (hRom1) on steroid production and on the activation of various signaling pathways. Using RT-PCR, immunoblotting, and immunohistochemistry, we found that INTL1 is present in human follicular cells. Using ELISA, we showed that INTL levels are similar in plasma and follicular fluid (FF) in control patients, whereas they are higher in FF than in plasma in PCOS patients. In KGN cells and hGLCs, insulin (10 À8 M), insulin-like growth factor-1 (IGF-1; 10 À8 M), and metformin (10 À2 M or 10 À3 M) increased INTL1 expression (mRNA and protein) after 12 and 24 h of stimulation. For metformin, this effect was mediated by adenosine monophosphate-activated kinase (PRKA). Furthermore, hRom1 increased nicotinamide phosphoribosyltransferase (NAMPT) expression in KGN and hGLCs. We also showed that hRom1 increased IGF-1-induced progesterone and estradiol secretion and this was associated with an increase in the STAR and CYP19A1 protein levels and an increase in IGF-1R signaling. Furthermore, all these data were abolished when NAMPT was knocked down in KGN cells, suggesting that INTL1 improves IGF-1-induced steroidogenesis through induction of NAMPT in hGLCs.
INTRODUCTION
INTELECTIN1 (INTL1, also named OMENTIN1, endothelial lectin HL-1, and intestinal lactoferrin receptor) is an adipokine produced predominantly by visceral adipose tissue in humans and rhesus monkeys [1] [2] [3] [4] . Mature INTL is a secretory glycoprotein consisting of 295 amino acids and N-linked oligosaccharides. It is a 120-kDa homotrimer in which 40-kDa polypeptides are bridged by disulfide bonds. A homolog of INTL1, referred to as INTL2, shares 83% amino acid identity with INTL1 [1] . The INTL1 and INTL2 genes are localized adjacent to each other in the human 1q22-q23 chromosomal region, which has been previously linked to type 2 diabetes mellitus in several populations. INTL1 is the major circulating form in human plasma [5] . It has been described as a calciumdependent lectin with affinity for galactofuranosyl residues that are constituents of pathogens and dominant immunogens [6] . Thus, one of the INTL1 functions is the specific recognition of pathogens and bacterial components. Furthermore, some evidence shows that INTL1 expression is altered by inflammatory states and obesity [5, 7, 8] . INTL1 enhances insulin action [2] . It is inversely related to obesity [5] and is increased after weight loss [9] , and is downregulated by insulin and glucose [10] .
INTL1 has also been linked to metabolic syndrome [11] , and polycystic ovary syndrome (PCOS) [10] . PCOS is one of the most common causes of female infertility, affecting 6%-10% of reproductive age women. It is characterized by irregular menses, hyperandrogenism, anovulation, and polycystic ovaries [12, 13] . Most PCOS patients are obese. Plasma INTL1 levels are higher in women than in men [5] and are decreased in women with PCOS compared with those in body mass index (BMI)-matched control subjects [10, 14] . Treatment with metformin for 3 or 6 mo significantly increased serum INTL1 levels as well as the INTL1-to-insulin ratio in PCOS patients [15, 16] . INTL1 plasma levels in regular menstrual cycles are different from those in irregular menstrual cycles in PCOS patients, suggesting that INTL1 could affect the secretion of hormones that regulate ovarian and menstrual functions or affect receptors for these hormones [17] . INTL1 is expressed in adipose tissue but also in reproductive tissues including the placenta and ovary in human, monkey, and sheep [2, 6, 18] . However, the physiological roles of INTL1 in these organs, a receptor, or relevant signal transduction pathways have still to be determined.
New functions of adipokines have been described in the reproductive field and more precisely in ovarian functions [19] . Furthermore, increasing evidence shows that the dysregulated expression of adipokines plays an important role in the pathology of PCOS. Leptin and its receptor are involved in folliculogenesis, ovarian steroidogenesis, and development of dominant follicles and oocytes. Increased serum leptin concentrations have been observed in women with PCOS in comparison to those in weight-matched controls in certain studies [20] [21] [22] [23] . Some evidence supports the fact that adiponectin (ADIPOQ) and its receptors ADIPOR1 and ADIPOR2 can modulate not only follicle growth but also embryo development in mice and humans [24] . A metaanalysis revealed that serum ADIPOQ levels are lower in women with PCOS than in BMI-matched healthy controls [25] . Resistin (RE-TN), RARRES2, and nicotinamide phosphoribosyltransferase (NAMPT) are also expressed in ovarian cells, and several studies have shown that these adipokines can modulate ovarian follicular development and steroidogenesis [26] [27] [28] [29] [30] [31] [32] .
The objectives of our work were to identify INTL1 in the human follicle and to study the regulation of its expression in human granulosa-lutein cells (hGLCs; luteal granulosa cells from women undergoing in vitro fertilization, and KGN cells) in response to follicle-stimulating hormone (FSH), insulin, insulin-like growth factor-1 (IGF-1), and two insulin sensitizers, metformin and rosiglitazone. We also investigated the effects and the molecular mechanism of human recombinant INTL1 on steroid production in these cells.
MATERIALS AND METHODS

Patients
Sixty infertile nonobese women (33 6 4 yr old, with BMI ,30) were recruited at the Service de médecine et Biologie de la Reproduction, CHRU de Tours, in 2011 for mechanical or male factor infertility without any known endocrinopathy (PCOS, hyperprolactinemia, hypo-and hypertrophism). Fifteen infertile nonobese women with PCOS (31 6 4 yr old, with BMI ,30) were also studied. The diagnosis of PCOS was based on the criteria proposed by the 2003 American Society for Reproductive Medicine/European Society of Human Reproduction and Embryology Rotterdam consensus [33] . This study was approved by the Hospital Ethical Committee (CHRU Bretonneau, France), and the patients gave their consent and did not receive any monetary compensation for participating in the study. Only one cycle was studied from each patient. Visceral (ATv) and subcutaneous (ATsc) adipose tissues from adult women (nonobese and nondiabetic), used as the positive control, were obtained from Tebu-Bio (Le Perray-en-Yvelines, France).
Collection and Processing of Follicular Fluid Samples
Follicular fluid (FF) was collected in sterile tubes preheated to 378C, which contained no culture medium. The entire content of the follicles with a mean diameter of !15 mm (between 15 and 22 mm) was aspirated. The FF samples of each follicle from individual patients were pooled. FF was collected from 30 infertile women, 15 with male and/or female tubal factor of infertility (control group) and 15 with PCOS (PCOS group). For the control group, 7 6 2 follicles were aspirated per patient, whereas in the PCOS group, approximately 13 6 4 follicles were aspirated per patient. Only FF free of blood contamination upon visual inspection was used. The FF samples were centrifuged at 400 3 g for 10 min to separate cell remnants, and the supernatant was stored at À808C in 2 aliquots for later use.
KGN Cell Culture
The human ovarian granulosa-like tumor cell line KGN was cultured in Dulbecco minimal essential medium (DMEM)-F12 medium (Sigma, St. Louis, MO) supplemented with 10% fetal calf serum and antibiotics (100 IU/ml penicillin, 100 lg/ml streptomycin [Sigma]) in a 5% CO 2 atmosphere at 378C. KGN cells were obtained in 2002 from Drs. Masatoshi Nomura and Hajime Nawata, Kyushu University, Japan [34] . The cells are undifferentiated and maintain the physiological characteristics of ovarian cells, including the expression of functional FSH receptor and the expression of CYP19A1 [34] .
Hormones and Reagents
Purified ovine FSH-20 (oFSH; lot no.AFP-7028D, 4453 IU/mg, FSH activity ¼ 175 times the activity of oFSH-S1) was a gift from National Institute of Diabetes and Digestive and Kidney Diseases, National Hormone Pituitary Program (Bethesda, MD). Recombinant human insulin-like growth factor-1 (IGF-1), insulin, and luteinizing hormone (LH) from human pituitary used for culture treatment were from Sigma. Recombinant human INTL1 was from R&D (Lille, France). Metformin was obtained from Sigma, and rosiglitazone was a gift from Dr. B. Staels (Lille, France).
Antibodies
Sheep anti-human INTL1 polyclonal antibody was purchased from R&D. Affinity-purified rabbit anti-human NAMPT (code BL2122) polyclonal antibody was purchased from Bethyl Laboratories, Inc., (Montgomery, TX). Rabbit polyclonal antibodies to IGF-1R-beta subunit (C20), phospho-MAPK3/ 1 (Thr202/Tyr204), phospho-MAPK14 (Thr180/Tyr182), phospho-AKT (Ser 473), and phospho-PRKA alpha Thr172 were obtained from New England Biolabs, Inc. (Beverly, MA). Rabbit polyclonal antibodies to PRKAA and IRS-1 were purchased from Upstate Biotechnology, Inc. (Lake Placid, NY). Rabbit polyclonal antibody to MAPK1 (C14) and MAPK14 (C20) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). CYP11A1, STAR, and HSD3B antibodies were a gift from Dr. Dale Buchanan Hales (University of Illinois, Chicago, IL) and Dr. Van Luu-The (CHUL Research Center and Laval University, Quebec, Canada), respectively. Mouse monoclonal antibodies to vinculin and CYP19A1 were purchased from Sigma and Serotec (Varilhes, France), respectively. PY20 antibodies were obtained from BD Biosciences (Le Pont de Claix, France). All antibodies were diluted 1:1000 in Western blotting.
Isolation and Culture of Human Granulosa-Lutein Cells
The hLGCs were collected from preovulatory follicles during oocyte retrieval for in vitro fertilization (IVF). The ovarian stimulation protocol and IVF and intracytoplasmic sperm injection procedures used have already been reported [28, 35] . After isolation of cumulus oocyte complexes (used for IVF), FF samples were pooled and then centrifuged (400 3 g, 10 min). To remove most of the red blood cells, the pellet was centrifuged (400 3 g, 20 min) on a two-layer discontinuous Percoll gradient (40%, 60% in Ham medium, Gibco-BRL; Life Technologies, Cergy Pontoise, France). The 40% fraction was collected and treated with hemolytic medium (NH 4 Cl 10 mmol/l in Tris HCl, pH 7.5 [Sigma]) to remove the remaining red blood cells. Following centrifugation, the pellet was washed with fresh medium (Ham F12), cells were counted in a hemocytometer, and cell viability was determined using Trypan Blue dye exclusion (Sigma). Cells were cultured in McCoy 5A medium supplemented with 20 mmol/L Hepes, penicillin (100 U/ml), streptomycin (100 mg/L), L-glutamine (3 mmol/L, 0.1% bovine serum albumin, 0.1 lmol/L androstenedione, 5 mg/L transferrin, 20 lg/L selenium) and 5% fetal bovine serum. The cells were initially cultured for 48 h with no other treatment and then incubated in fresh culture medium with or without test reagents for the appropriate time. All cultures were kept under a water-saturated atmosphere of 95% air/5% CO 2 at 378C. on the day of oocyte retrieval. Each concentration was determined by ELISA as described in Materials and Methods. The mean of these data is presented. Different letters indicate significant differences at P , 0.05. E) The INTL1 gene expression was measured by quantitative real-time-PCR in hGLCs from PCOS (n ¼ 8) and control (n ¼ 10) patients. ACTB was used as the reference gene. The mean of these data are presented. Different letters indicate significant differences at P , 0.05.
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agarose gel stained with ethidium bromide and the specificity of the amplified products was assessed by sequencing (Genome Express Co., Meylan, France). MMLV and RNase inhibitor (RNasin; were purchased from Promega, Madison, WI), and RT-PCR consumables were from Sigma.
Real-Time Quantitative PCR
Targeted cDNAs were quantified by real-time PCR using SYBR Green Supermix (Bio-Rad, Marnes la Coquette, France) and 250 nM of specific primers as indicated in Table 1 in a total volume of 20 ll in a MyiQ Cycle device (Bio-Rad). Samples were tested in duplicate on the same plate, and PCR amplification with water instead of cDNA was done systematically as a negative control. After incubation for 2 min at 508C and a denaturation step of 10 min at 958C, samples were subjected to 40 cycles (30 sec at 958C, 30 sec at 608C, 30 sec at 728C), followed by the acquisition of the melting curve. Primers' efficiency (E) was performed from serial dilutions of a pool of obtained cDNA and ranged from 1.8 to 2. Three reference genes were used, PPIA, RPL19, and ACTB. For each gene, expression was calculated according to primer efficiency and quantification cycle (Cq), where expression ¼ E ÀCq . Then, relative expression of the NAMPT reference gene was analyzed. Only one reference gene is represented in the Figures.
Stable NAMPT Knockdown Using Lentiviral Vectors
Short hairpin RNA (shRNA) was designed according to rules described previously [36] . The sequence of shRNA against NAMPT, called NAMPT1, was 5 0 -GAGTGTTACTGGCTTACAA-3 0 , and a second shRNA, called NAMPT2 (5 0 -GAGTGTTACGGGGTTCCAG-3 0 ), was from published reports [37] . Scrambled shRNA sequence was created by mutating critical bases on shRNA against NAMPT, namely, 5 0 -GAGTGTTACGGGGTTCCAG-3 0 . All shRNAs were subcloned into the pSicoR lentiviral vector [38] , in which shRNA is driven by a U6 promoter, and a reporter green fluorescent protein (GFP) expression cassette is driven by an immediate early promoter of cytomegalovirus (CMV). We produced G protein of vesicular stomatitis virus (VSV-G) pseudotyped shRNA lentiviral vectors. Lentiviral transductions were conducted at a multiplicity of infection of 6. Two days after transduction, cells were treated with puromycin (2 lg/ml), and the stable cell line (KGN) was established.
Adenoviruses and Infection of Human Granulosa-Lutein Cells
Dominant negative PRKA adenovirus (AdN AMPK) was constructed from PRKAA1 carrying the Asp-157 to Ala (D157A) mutation as described previously [39] . Recombinant adenovirus was propagated in HEK293 cells, purified by cesium chloride density centrifugation, and stored as described previously [39] . hCGLs were infected with 20 plaque-forming units (PFU) /cell adenovirus (AdN AMPK and AdN GFP adenovirus [AdN GFP as the control]) in serum-starved McCoy 5A as previously described [40] . After 2 h, 1 additional volume of serum-starved McCoy 5A was added, and the cells were cultured for 24 h in the presence or absence of metformin (10 À2 and 10 À3 M). Preliminary studies revealed that within 24 h of infection (20 PFU/cell) with a GFP-expressing virus, the majority of hGLCs (.90%) expressed GFP.
Protein Extraction and Western Blotting
hGLCs purified on a Percoll gradient, KGN cells, and ATv and ATsc were homogenized in buffer A (10 mM Tris [pH 7.4], 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.5% Nonidet P-40) containing various protease inhibitors (2 mm PMSF, 10 lg/ml leupeptin, 10 mg/ml aprotinin) and phosphatase inhibitors (100 mM sodium fluoride, 10 mM sodium pyrophosphate, 2 mM sodium orthovanadate) as previously described [41, 42] . Lysates were incubated on ice for 30 min and then centrifuged at 12 000 3 g for 20 min at 48C. The protein concentration in the resulting supernatants was then determined using the BCA protein assay. After denaturation, the samples were subjected to electrophoresis on 12% SDS-polyacrylamide gels and transferred onto nitrocellulose membranes (Schleicher and Schuell, Ecquevilly, France). The membrane was blocked for 30 min in TBS-Tween-milk 5% and incubated for 16 h with appropriate primary antibodies at a 1:1000 final dilution. Finally the blots were incubated for 1 h and 30 min at room temperature with horseradish-peroxidase (HRP)-conjugated anti-rabbit, anti-mouse, or anti-sheep immunoglobulin G (IgG; dilution 1/5000). Proteins were detected by enhanced chemiluminescence (Western Lightning Plus-ECL, Perkin Elmer) using a G:Box SynGene (Ozyme) with GeneSnap software (release 7.09.17; Chicago, IL). Signals detected were quantified with the GeneTools software (release 4.01.02; Synegene, Fredrick, MD). The results are expressed as the intensity signal in arbitrary units after normalization as indicated in the Figure legends.
Immunoprecipitation
After normalization for protein concentration (250 lg) of KGN cell lysates, IGF-1R or IRS1 was immunoprecipitated from the supernatants by using 5 lg of appropriate antibodies at 48C overnight. The immunocomplexes were precipitated with 40 ll of protein A-agarose for 1 h at 48C. After two sequential washes using buffer A with a 1/2 dilution, the resulting pellets were boiled for 4 min in reducing Laemmli buffer containing 80 mM dithiothreitol. Proteins were resolved by SDS-PAGE and transferred to nitrocellulose membranes. Blots were blocked and probed with the various antibodies as indicated in the Figure legends. 
CLOIX ET AL.
Progesterone and Estradiol Radioimmunoassay
The concentration of progesterone and estradiol in the serum-free culture medium of KGN (scrambled, NAMPT-/-1 [cells expressing a shRNA against NAMPT], NAMPT-/-2 [cells expressing a second shRNA against NAMPT], or parental KGN cells) and hGLCs was measured after 48 h of incubation with INTL1 with or without IGF-1, FSH, or LH by a radioimmunoassay protocol as previously described [41, 42] . The limit of detection of progesterone was 12 pg/ tube (60 pg/well) and the intra-and interassay coefficients of variation were less than 10% and 11%, respectively. The limit of detection of estradiol was 1.5 pg/tube (7.5 pg/well), and the intra-and interassay coefficients of variation were less than 7% and 9%, respectively. Results are expressed as the concentration of steroids/cell protein concentration/well.
Immunohistochemistry
Ovary sections from women (age 34 6 2 yr, nonobese non-PCOS) obtained from Euromedex (Souffelweyersheim, France) were deparaffinized, hydrated, and microwaved for 5 min in antigen unmasking solution (Vector Laboratories, Inc., AbCys, Paris, France) and then allowed to cool to room temperature. After being washed in a phosphate-buffered saline (PBS) bath for 5 min, sections were immersed in peroxidase-blocking reagent for 10 min at room temperature to quench endogenous peroxidase activity (DAKO Cytomation, Dako, Ely, UK). After 2 washes in a PBS bath for 5 min, nonspecific background was eliminated by blocking with 5% lamb serum in PBS for 20 min, followed by incubation overnight at 48C with PBS containing sheep primary antibody raised against INTL1 (1:100). Sections were washed twice for 5 min each time in a PBS bath and were incubated for 30 min at room temperature with a ''ready-to-use'' labeled polymer-HRP anti-sheep (Envision Plus HRP system; Dako Cytomation). The sections were then washed twice in PBS, and the staining was revealed by incubation at room temperature with 3,3 0 -diaminobenzidine tetrahydrochloride (liquid DABþsubstrate chromogen system; DakoCytomation). Negative controls involved replacing primary antibodies with sheep IgG or by using INTL1 blocking peptide (Antibodiesonline GmbH, France). 
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INTL ELISA Assay
INTL levels in plasma and FF were measured using a commercially available ELISA (Biovendor, Heidelberg, Germany), according to the manufacturer's protocol, with an intra-assay coefficient of variation of ,6%.
Statistical Analysis
All experimental results are expressed as means 6 SEM. Statistical analyses were carried out using a t-test or one-way analysis of variance (ANOVA; for comparison of various means), and if ANOVA revealed significant effects, it was supplemented with the Fisher test. A P value of ,0.05 was considered significant.
RESULTS
INTL1 Is Expressed in Human Ovarian Cells
We determined the expression of INTL1 in hLGCs and in the human granulosa tumor cell line KGN. As shown in Figure  1A , using RT-PCR, we amplified 1 cDNA fragment of 379 bp, corresponding to INTL1. We found that the transcript of INTL1 is expressed in hGLCs and, as expected, is strongly in the visceral adipose tissue (Fig. 1A) . Immunoblotting of protein extracts revealed the presence of INTL1 (40 kDa) in hGLCs and KGN cells (Fig. 1B) . Immunohistochemistry with human ovarian follicle sections showed that INTL1 is present in granulosa cells but also in cumulus cells, oocytes, and theca cells (Fig. 1C) . We also measured the concentration of INTL in plasma and FF of infertile control and PCOS women. As shown in Figure 1D , and as expected [14] , women with PCOS had significantly lower plasma INTL levels than those of BMImatched control subjects. Furthermore, the INTL levels were similar in plasma and FF in infertile control subjects, whereas they were was higher in FF than in plasma in PCOS patients (P , 0.05). We also observed that INTL1 mRNA expression was two-fold higher in hGLCs from PCOS than those from control patients (Fig. 1E) . Thus, INTL1 is expressed in human ovarian follicles and more particularly in granulosa cells.
INTL1 Expression Is Regulated by Insulin, IGF-1, and FSH in Granulosa-Lutein Cells
We also determined whether insulin, IGF-1, and FSH, hormones involved in the ovarian functions, were able to regulate INTL1 expression. Cells starved overnight in culture medium without serum were incubated for 12, 24, or 48 h with insulin (10 À8 M), IGF-1 (10 À8 M), or FSH (10 À8 M). We showed that after 12 or 24 h of stimulation, these three hormones increased INTL1 mRNA expression, whereas after 48 h of stimulation, they inhibited it (Fig. 2) . We also confirmed these results at the INTL1 protein levels (data not shown). Similar results were observed in KGN cells (data not shown).
INTL1 mRNA and Protein Expression Is Increased by Metformin Through PRKA Signaling Pathways in Granulosa-Lutein Cells
We next investigated the effect of two insulin sensitizers, metformin and rosiglitazone, on INTL1 expression in primary hGLCs (Fig. 3A) and KGN (Fig. 3B) cells. It has been reported that these two insulin sensitizers improve secondary pathologies that are frequently associated with insulin resistance such as PCOS. Overnight-starved cells in culture medium without serum were incubated for different times (12 and 24 h) with different concentrations of metformin (10 À3 and 10 À2 M) or rosiglitazone (10 À6 M). These doses of metformin and rosiglitazone are known to affect human granulosa cell steroidogenesis [27] . We showed that after 12 or 24 h of stimulation, metformin increased INTL1 mRNA expression in a dose-independent manner, whereas rosiglitazone (10 À6 M) had no effect (Fig. 3) . We next examined whether these effects of metformin on INTL1 mRNA were also observed at the protein level. As shown in Figure 3 (right panel), metformin treatment (10 À3 and 10 À2 M) for 24 h resulted in a two-fold increase in the level of INTL1 protein in hGLCs (Fig. 3A) and KGN cells (Fig. 3B) . Rosiglitazone treatment (10 À6 M, 24 h) did not affect CLOIX ET AL. the amount of INTL1 protein (data not shown). We have previously shown that PRKA is important in the molecular mechanism of metformin action in granulosa cells [43, 44] .
To determine whether PRKA activation through its phosphorylation is involved in the regulation of INTL1 expression in response to metformin in hGLCs, we used an adenoviral vector to overexpress a dominant-negative PRKA (AdN AMPK) or a GFP (AdN GFP) adenoviral vector as the control. As shown in Figure 4A , expression of AdN AMPK in hGLCs strongly reduced the metformin-induced increase in mRNA and protein INTL1 expression (Fig. 4, A and B) . The expression of AdN GFP under the same conditions did not affect the stimulatory effects of metformin. Similar results were observed in KGN cells (data not shown).
Human Recombinant INTELECTIN1 Increases NAMPT Expression in hGLCs and KGN Cells
We next examined whether human recombinant INTL1 could affect the expression of other adipokines already described in human granulosa cells, such as NAMPT, RARRES2, and RETN, (ADIPOQ is not expressed in granulosa-lutein cells) [28, 29, 41] . Overnight-starved hGLCs were incubated for 24 h with different concentrations of human recombinant INTL1 (0, 10, 50, 100, and 250 ng/ml). We showed that after 24 h of stimulation, human recombinant INTL1 increased NAMPT mRNA and protein expression in a dose-dependent manner (Fig. 5, A and B) , whereas it did not significantly affect the expression of RETN and RARRES2 (data not shown). Similar results were observed in KGN cells 
Effect of Human Recombinant INTELECTIN1 on Basal and IGF-1-, FSH-, or LH-Induced Progesterone and Estradiol Production by hGLCs and KGN Cells
We next investigated the effects of INTL1 treatment on steroidogenesis in hGLCs and KGN cells (Fig. 6 ). Cells were incubated in serum-free medium with human recombinant INTL1 (250 ng/ml) for 48 h in the presence or absence of IGF-1 (10 À8 M), FSH (10 À8 M), and/or LH (10 À8 M). As expected, IGF-1, FSH, or LH treatment alone increased progesterone and estradiol secretion in primary hGLCs (Fig. 6 , A and C [40] ) and KGN cells (Fig. 6, B and D [41] ). In primary granulosalutein cells, in the presence of IGF-1, INTL1 treatment (250 ng/ ml) produced a two-fold increase in secretion of progesterone (Fig. 6A , P , 0.001) and estradiol (Fig. 6C, P , 0.001) , whereas no effect of INTL1 was observed in the absence or presence of FSH and/or LH. In KGN cells, similar effects were observed (Fig. 6, B and D) .
INTL1 Increases IGF-1-Induced Steroid Production and STAR and CYP19A1 Protein Levels Through NAMPT in KGN Cells
We determined whether the effect of INTL1 on steroidogenesis induced by IGF-1 was mediated by NAMPT. We used the shRNA technology to specifically knock down the expression of NAMPT in KGN cells. Two days after the lentiviral infection, the NAMPT-/-1 and NAMPT-/-2 cells showed almost 100% knockdown of NAMPT mRNA, protein (Fig. 7, A and B) and activity (data not shown). The scrambled cells produce a shRNA targeting no known mRNAs. They did not differ significantly from the parental KGN cells in any of the experiments performed (data not shown). The NAMPT-/-1, NAMPT-/-2, and scrambled cells were incubated in serum-free medium with human recombinant INTL1 (250 ng/ml) for 48 h in the presence or absence of IGF-1 (10 À8 M). As shown in Figure 7 , C and D, INTL1 treatment increased IGF-1-induced progesterone and estradiol secretion in scrambled cells but not in NAMPT-/-1 and NAMPT-/-2.
We next examined whether this stimulatory effect of INTL1 mediated by NAMPT on progesterone and estradiol production was due to effects on the three key enzymes of steroidogenesis (HSD3B, CYP11A1, and CYP19A1) and/or of STAR, an important cholesterol carrier. INTL1 treatment (250 ng/ml, 48 h) in the presence of IGF-1 increased by two-fold and 1.5-fold the production of STAR (Fig. 8A) and CYP19A1 (Fig. 8B) proteins, respectively, in scrambled KGN cells, whereas these CLOIX ET AL. effects were not observed in NAMPT-/-1 (Fig. 8, A and B) or NAMPT-/-2 (data not shown). However, INTL1 treatment did not affect IGF-1-induced HSD3B and CYP11A1 in scrambled or NAMPT-/-1 and NAMPT-/-2 cells (data not shown).
Effect of Human Recombinant INTL1 on IGF-1-Induced IGF-1R-beta, IRS1, and MAPK3/1 Phosphorylation in KGN Cells
We next investigated the molecular mechanisms involved in the effect of INTL1 on steroid production in response to IGF-1 in KGN cells. More precisely, we determined whether INTL1 treatment could modulate IGF-1R signaling through NAMPT. Scrambled and NAMPT-/-1 KGN cells were incubated in serum-free medium supplemented with recombinant human INTL1 (250 ng/ml) for 48 h (conditions used to measure progesterone and estradiol production) in the absence or presence of IGF-1 (10 À8 M) treatment for 10 min. As shown in Figure 9 , IGF-1 treatment alone increased by approximately 2-fold (P , 0.05) tyrosine phosphorylation of IGF-1R receptor b subunit and IRS-1 and phosphorylation levels of MAPK3/1 in scrambled and NAMPT-/-1 cells. Treatment with only recombinant human INTL1 did not affect basal phosphorylation of IGF-1Rb, IRS1, and MAPK3/1 in both cell types, whereas it increased by approximately two-fold IGF-1-induced tyrosine phosphorylation of IGF-1Rb subunit and IRS-1 and phosphorylation of MAPK3/1 in scrambled cells but not in NAMPT-/-1 ( Figure 9 ). We observed the same results with NAMPT-/-2 as those with NAMPT-/-1 (data not shown).
DISCUSSION
In this study. we report for the first time that INTL1 is expressed in human ovarian cells. In hGLCs and KGN cells, we showed that INTL1 expression is regulated by insulin, IGF-1, FSH, and metformin. Metformin-induced INTL1 is mediated through PRKA. We have also shown that INTL1 increased NAMPT expression in a dose-dependent manner. It enhanced IGF-1-induced steroid production, and this was associated with increased STAR and CYP19A1 protein levels and IGF-1R 
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signaling in both hGLCs and KGN cells (Fig. 10) . Furthermore, NAMPT knockdown by shRNA abolished these effects in KGN cells.
Here we have shown that plasma and FF INTL concentrations were not significantly different in control women, whereas in PCOS patients, INTL concentrations were almost twice as high in FF compared to that in plasma. These results suggest an increase in the production of INTL in ovarian cells from PCOS patients compared with control subjects. However, it has been reported that in addition to decreased plasma INTL1 levels in women with PCOS, compared with control patients, there were significantly lower levels of INTL1 mRNA and protein in omental adipose tissue of women with PCOS [10] . In our study, we confirmed the lower INTL plasma levels in PCOS patients. Furthermore we showed that the FF and hGLCs mRNA expression INTL levels were increased in PCOS patients. However, we also observed that INTL1 mRNA expression was insulin-responsive and INTL1 was a positive regulator of CYP19A1 in control hGLCs. However, PCOS ovarian follicles are generally insulin-resistant [45, 46] and CYP19A1 deficient [47] . Thus, our results suggest that the potential link between INTL1 and PCOS is unclear at the present time and needs to be clarified.
Here we have shown that INTL1 gene expression was significantly increased after 24 h of stimulation by insulin or metformin in vitro in cultured granulosa-lutein cells. In omental adipose tissue explants, insulin dose-dependently decreased INTL1 mRNA expression, protein levels, and secretion after 24 h of stimulation into conditioned medium [10] , suggesting a different regulation of INTL1 expression by insulin according to various tissues. We also observed that the insulin sensitizer metformin strongly increased INTL1 gene and protein expression through PRKA in granulosa-lutein cells. Metformin, a derivative of biguanide, is an insulin-sensitizing agent used to treat type 2 diabetes mellitus and PCOS [48] . In women with PCOS, metformin treatment restores the cyclic nature of menstruation and increases ovulation (by improving follicular growth), fertilization, and pregnancy rates [49] . These improvements have been attributed to decreases in the level of insulin, subsequently attenuating a hyperandrogenic status. In the human KGN granulosa-cell line, metformin enhances insulin action and more precisely glucose uptake and thereby could facilitate follicle growth [50] . In our study, we have shown that metformin increases INTL1 expression and INTL1 enhances IGF-1R signaling through NAMPT. IGF-1 and insulin have commons signaling pathways and functions. Thus, the insulin sensitizing effects of metformin could be mediated by INTL1 in human granulosa cells.
In granulosa-lutein cells (hGLCs and KGN cells), we observed that INTL1 increased NAMPT expression in a dosedependent manner, which is essential for the stimulatory effect of INTL1 on IGF-1-induced steroidogenesis. NAMPT is a ratelimiting enzyme in the biosynthetic pathway of nicotinamide adenine dinucleotide [51] and is ubiquitously expressed in many tissues including human granulosa cells [27, 30] . NAMPT is a homodimeric protein that exhibits both an intracellular enzymatic activity leading to NAD synthesis and an extracellular form as a cytokine function via binding to its hypothetical receptor [52] . The question is how NAMPT in response to INTL1 can increase IGF-1R signaling in human granulosa cells. NAMPT was initially reported to mimic the effects of insulin by binding to the insulin receptor (IR) and by stimulating the phosphorylation of downstream components [53] . However, the original work describing NAMPT binding to IR has been retracted [53] . Therefore, IR is no longer considered a NAMPT receptor, although there is evidence that regulation of insulin signaling pathways at the level of IRSs, Akt, and MAPK3/1 is implicated in producing the pathophysiological effects of NAMPT. NAMPT activity leads to NAD release, a cofactor for NAD-consuming enzymes such as sirtuins. Sirtuins (SIRTs) are NAD-dependent histone deacetylases that regulate gene expression, differentiation, and development. SIRT1 is expressed in human ovary and in granulosa-lutein cells [27, 54] . SIRT1 activation ameliorates insulin sensitivity and in Leydig cells, SIRT1 promotes steroidogenesis [55] . Interestingly, SIRT1 modulates insulin/ IGF-1 signaling through various mechanisms. It upregulates IGF-1 level by depressing IGFBP1 [56] and enhances insulin/ IGF-1 signaling by deacetylation of IRS2, which increases downstream signaling [57] . Thus, INTL1 through NAMPT expression could increase IGF-1-induced steroidogenesis through these mechanisms.
INTL1 and NAMPT are two adipokines that increase insulin sensitivity. In the ovary, insulin and IGF-1 act synergistically with FSH to augment estrogen production by granulosa cells and with LH to augment androgen production by thecal stromal cells. PCOS is often associated with hyperinsulinemia and peripheral insulin resistance. Whether the ovary is resistant to insulin is a matter of controversy. Some studies showed that insulin resistance occurs in the ovary in PCOS [58] . However, -beta subunit and IRS-1 were immunoprecipitated from whole cell lysates, and samples were subjected to Western blotting with antibodies against PY20. Membranes were then reprobed with IGF-1R-beta subunit or IRS-1 antibodies to evaluate IGF-1R-beta subunit or IRS-1 levels in each lane. To determine MAPK3/1 phosphorylation, whole lysates were resolved by SDS-PAGE and then transferred to nitrocellulose membranes, and phosphorylation of MAPK3/1 was analyzed with polyclonal antibodies raised against phosphor-MAPK3/1. To determine the level of phosphorylation, blots were stripped and reprobed with antibodies against MAPK1. Right panel) The phosphorylation:total protein ratio was determined and plotted. Values are means 6 SEM from three independent experiments. Different letters indicate significant differences (P , 0.05).
little is known about the biological significance of this metabolic phenotype to ovary dysfunction. In granulosa-lutein cells isolated from ovaries of women with classic PCOS, insulin action on glucose metabolism is significantly decreased, whereas insulin action on steroidogenesis is unchanged compared with granulosa-lutein cells from control women [59, 60] . This result suggests that in PCOS, there is selective insulin resistance in the ovary. Insulin resistance has also a direct negative effects on oocyte quality (for review see [61] ). NAMPT is expressed in human granulosa cells but also in human oocytes [27] . Taken together, INTL1 and NAMPT, by modulating insulin sensitivity in granulosa cells, could affect ovarian functions. However, whether these adipokines affect insulin sensitivity in vivo in human ovary it remains to be determined.
We have shown that INTL1 through NAMPT expression increases IGF-1-induced steroid production in hGLCs and KGN cells. We have previously shown that ADIPOQ [41] and NAMPT [27] also increase IGF-1-induced progesterone and estradiol secretions, whereas RARRES2 [28] and RE-TN [29] decrease them in hGLCs. Here, we observed that INTL1, through NAMPT expression, increased IGF-1-induced STAR and CYP19A1 protein level (HSD3B and CYP11A1 protein levels were not affected). These results could explain the increase in progesterone and estradiol secretion in response to IGF-1. In the present study, we have also shown that INTL1, through NAMPT, increased IGF-1-induced MAPK3/1 phosphorylation, whereas we did not observe an effect on Akt signaling pathway (data not shown). The potential involvement of MAPK3/1 in the regulation of steroidogenesis is still a matter of debate [62, 63] . Thus, the involvement of MAPK3/1 in the INTL1 effects on human granulosa-lutein cell steroidogenesis remains to be determined.
In conclusion, INTL1 is expressed in human ovarian cells. In contrast to those in control patients, INTL levels are higher in FF than in plasma in PCOS patients. In granulosa-lutein cells, INTL1 expression is increased in the short term (12 or 24 h) by various hormones involved in follicle development and the insulin sensitizer metformin. Furthermore, INTL1, through induction of NAMPT expression, ameliorates IGF-1-induced steroidogenesis and IGF-1R signaling. Thus, INTL1 could be involved in ovarian functions. Further investigations are required to understand its role in the pathophysiology of PCOS.
